Vergoeding 2019-2023 voor ATC-subgroep L04AG05 : Vedolizumab
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022* | 2023* | |
|---|---|---|---|---|---|
|
L04AG05 Vedolizumab
|
36.733.695 | 42.596.426 | 50.204.262 | 55.427.788 | 62.975.041 |
| Totaal | 36.733.695 | 42.596.426 | 50.204.262 | 55.427.788 | 62.975.041 |